Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 24Thoracic 3Gynecologic 2Genitourinary 2Breast 2Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 140Head and Neck Neoplasms 114Carcinoma, Non-Small-Cell Lung 49Thyroid Neoplasms 42Melanoma 36Nasopharyngeal Carcinoma 35Mouth Neoplasms 35Ovarian Neoplasms 30Breast Neoplasms 30Oropharyngeal Neoplasms 29Colorectal Neoplasms 29Neoplasm Metastasis 26Uterine Cervical Neoplasms 24Lung Neoplasms 22Neoplasms 20Carcinoma, Squamous Cell 20Carcinoma, Renal Cell 20Carcinoma 19Stomach Neoplasms 18Pancreatic Neoplasms 17Prostatic Neoplasms 16Esophageal Neoplasms 16Endometrial Neoplasms 16Triple Negative Breast Neoplasms 15Laryngeal Neoplasms 15Sarcoma 14Urinary Bladder Neoplasms 13Hypopharyngeal Neoplasms 12Carcinoma, Transitional Cell 12Salivary Gland Neoplasms 11

Interventions

pembrolizumab 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma Of Esophagus × Head & Neck × 30 days × Clear all
NCT04389632 2026-05-11

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Seagen Inc.

Phase 1 Recruiting
1,006 enrolled
GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Adenocarcinoma Of Esophagus, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡